Moderna's experimental coronavirus vaccine gets FDA's 'fast track' status

(Reuters) – Moderna Inc said on Tuesday its experimental coronavirus vaccine had gained the U.S. Food and Drug Administration’s “fast track” designation.

The agency’s fast track status is designed to expedite the review of treatments and vaccines meant for serious conditions.

Reporting by Manas Mishra in Bengaluru; Editing by Amy Caren Daniel

Our Standards:The Thomson Reuters Trust Principles.

source: reuters.com

🕐 Top News in the Last Hour By Importance Score

#	Title	📊 i-Score
1	Global executions at highest level since 2015, report says	🟢 85 / 100
2	IRS to share info with ICE about some undocumented immigrant taxpayers	🔴 75 / 100
3	Gaza is a 'killing field', says UN chief, as agencies urge world to act on Israel's blockade	🔴 75 / 100
4	Brits in Greece face chaos as workers to take part in 24-hour strike	🔴 72 / 100
5	Deep Cogito emerges from stealth with hybrid AI ‘reasoning’ models	🔴 72 / 100
6	Hawaii's Kilauea volcano spews fountains of lava in latest eruption episode	🔴 65 / 100
7	Virgin River star and Yellowstone breakout teamed up in this ‘secretly amazing’ drama film	🔵 45 / 100
8	Cheese will last longer and ‘stay creamy’ if stored with 1 kitchen item	🔵 35 / 100
9	Incredible monorail systems from around the world – including a network that travels through a block of flats and a US line with breathtaking views of a top tourist city	🔵 35 / 100
10	Stacey Solomon shares special 'baby' announcement just in time for Easter	🔵 35 / 100

View More Top News ➡️